Side effects, including nausea (44% vs 44%), constipation (28% vs 29%), diarrhea (24% vs 23%), and vomiting (15% vs 21%), were similar between groups and mainly occurred during the therapy titration phase
Cardiovascular Health SupportMay contribute to the proper functioning of the heart and circulatory system, especially in physically active adults
Patients with chronic knee pain reported relief lasting over 6 months in retrospective observations
It works well as a refreshing breakfast or a small meal when appetite feels lower
When combined with diet and physical activity changes, brand-name Wegovy is approved by the Food and Drug Administration (FDA) for the following purposes: Weight loss in patients 12 years or older with obesity Body weight reduction in adults who are overweight and have at least one weight-related condition, such as high blood pressure, obstructive sleep apnea (OSA), or Type 2 diabetes Cardiovascular risk reduction in adults with heart disease and either obesity or overweight Treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis Wegovy is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist)
Many patients tell him they can finally stick with healthier eating patterns because they feel full sooner and no longer feel driven to eat certain foods
